When did SILEXION THERAPEUTICS CORP (SLXN) report earnings last quarter?
SILEXION THERAPEUTICS CORP (SLXN) last reported earnings on 11/12/2025.
SILEXION THERAPEUTICS CORP (SLXN) Earnings History & Surprises
NASDAQ:SLXN • KYG1281K1307
Current stock price
1.605 USD
-0.06 (-3.68%)
At close:
1.6017 USD
0 (-0.21%)
After Hours:
SLXN Earnings overview
Past quarterly earnings results for SILEXION THERAPEUTICS CORP (SLXN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q4 / 2025
- EPS Estimate
- -$1.14
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Nov 12, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$2.88
- EPS Surprise
- 16.96%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -2.88 | -3.47 | 16.96% | 90.54% | - | - | ||
| Q2 2025 | -4.32 | -3.67 | -17.65% | - | - | - | ||
| Q1 2025 | -3.90 | -3.37 | -15.86% | - | - | - | ||
| Q4 2024 | -311.40 | -14.99 | -1,976.83% | - | - | - | ||
| Q3 2024 | -30.45 | 0.00 | - | - | - | - | ||
| Q2 2024 | - | - | - | - | ||||
| Q1 2024 | - | - | - | - | ||||
| Q4 2023 | - | - | - | - | ||||
| Q3 2023 | - | - | - | - | ||||
| Q2 2023 | - | - | - | - | ||||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | - | - | - | - | ||||
| Q3 2022 | - | - | - | - | ||||
| Q2 2022 | - | - | - | - | ||||
| Q1 2022 | - | - | - | - | ||||
| Q4 2021 | - | - | - | - | ||||
| Q3 2021 | - | - | - | - | ||||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-498.35%
Max EPS beat (4)
16.96%
Min EPS beat (4)
-1,976.83%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, SLXN has beaten EPS estimates in 1 out of 4 releases
In the last 4 quarters, SLXN reported -498.3% below the EPS estimates on average.
Related analysis
SILEXION THERAPEUTICS CORP / SLXN Earnings FAQ
Can you provide information on whether SILEXION THERAPEUTICS CORP beat earnings estimates in the last quarter?
SILEXION THERAPEUTICS CORP (SLXN) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often SILEXION THERAPEUTICS CORP beats earnings estimates?
In the last 4 quarters, SILEXION THERAPEUTICS CORP (SLXN) has beaten EPS estimates in 1 out of 4 releases.